Physician profile
Grace Lee
NPI 1932151404
$422.89
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.14 · 2022: $103 · 2023: $37.03 · 2024: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $154.61 | 2024 | |
| Novo Nordisk INC | $102.69 | 2022 | |
| Roche Diagnostics Corporation | $37.55 | 2024 | Virtuoso System For Ihc |
| Incyte Corporation | $23.47 | 2024 | Pemazyre, Monjuvi |
| Daiichi Sankyo INC. | $21.69 | 2023 | |
| Merck Sharp & Dohme LLC | $19.79 | 2024 | Keytruda |
| Eisai INC. | $17.61 | 2024 | |
| Janssen Biotech, INC. | $16.77 | 2019 | |
| Haemonetics Corporation | $15.34 | 2023 | Teg6s Hemostasis System |
| Genentech USA, INC. | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.